BRIEF published on 03/17/2025 at 07:05, 1 year 7 months ago Biophytis avance dans le traitement de la sarcopénie Biophytis Essais Cliniques Sarcopénie BIO101 Phase III
BRIEF published on 03/17/2025 at 07:05, 1 year 7 months ago Biophytis Publishes Promising Sarcopenia Trial Results Biophytis Clinical Trial Sarcopenia BIO101 Phase 2 Results
REGULATED PRESS RELEASE published on 03/17/2025 at 07:00, 1 year 7 months ago Biophytis revolutionizes sarcopenia Biophytis announces groundbreaking results from SARA-INT Phase II trial for BIO101 in sarcopenia, confirming Phase 3 readiness. Publication in JCSM highlights efficacy and safety Biophytis Clinical Trial Sarcopenia Phase II SARA-INT
REGULATED PRESS RELEASE published on 03/17/2025 at 07:00, 1 year 7 months ago Biophytis révolutionne la sarcopénie Biophytis révolutionne la sarcopénie avec BIO101. Résultats prometteurs de l'étude SARA-INT publiés. Passage à la Phase 3 confirmé. Importante avancée dans le traitement de la sarcopénie Biophytis Traitement Étude Clinique Sarcopénie BIO101
BRIEF published on 03/06/2025 at 07:05, 1 year 8 months ago Biophytis participe à BIO-Europe Spring à Milan Biophytis Conference BIO-Europe Spring Innovation Biotechnologique Traitement Maladies Liées À L'âge
BRIEF published on 03/06/2025 at 07:05, 1 year 8 months ago Biophytis to Attend BIO-Europe Spring 2025 in Milan Biophytis Biotechnology Drug Development BIO-Europe 2025 Aging Diseases
REGULATED PRESS RELEASE published on 03/06/2025 at 07:00, 1 year 8 months ago Biophytis annonce sa participation à la conférence BIO-Europe Spring à Milan Biophytis annonce sa participation à la conférence BIO-Europe Spring à Milan pour discuter de son principal candidat médicament, BIO101, dans l'obésité et la sarcopénie Biophytis Conference BIO-Europe Spring Sarcopénie Obésité
REGULATED PRESS RELEASE published on 03/06/2025 at 07:00, 1 year 8 months ago Biophytis announces its participation to the BIO-Europe Spring 2025 in Milan Biophytis announces participation in BIO-Europe Spring 2025 in Milan. Chief Business Officer to attend meetings. Focus on lead drug candidate BIO101 in obesity and sarcopenia Biophytis Sarcopenia BIO101 Obesity BIO-Europe Spring 2025
BRIEF published on 02/25/2025 at 07:05, 1 year 8 months ago Biophytis au 15ème Congrès International sur la Fragilité et la Sarcopénie Biophytis Sarcopénie Traitements Innovants Fragilité Congrès ICFSR
BRIEF published on 02/25/2025 at 07:05, 1 year 8 months ago Biophytis to Present at 15th International Conference on Frailty and Sarcopenia Research Biophytis Sarcopenia BIO101 ICFSR 2025 Obesity Research
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:05, 13 minutes ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 19 minutes ago Custodian Property Income REIT plc: Further momentum with majority share-based acquisition strategy, purchasing an £11.0m property portfolio from eight syndicated investment vehicles
Published on 11/09/2026 at 08:00, 19 minutes ago Eleving Group achieves record-high net profit of EUR 27.8 million in the first nine months of 2026
Published on 11/09/2026 at 07:00, 1 hour 19 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 19 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 19 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 19 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
